NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
- Institution
- Coriell Institute for Medical Research, NJ
- Principal investigator
- Xiaoxin Luke Chen
- Funding
- $579K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY This multiple-PI R01 proposal is designed to incorporate both in vitro and in vivo approaches to elucidate the role of the NRF2-ACSS2 axis in alcohol-induced metabolic reprogramming and esophageal pathology. We hypothesize that the NRF2-ACSS2 axis mediates metabolic reprogramming in alcohol-associated esophageal pathology. We will test this hypothesis using human cells and genetically modified mice through three independent and complementary Specific Aims. In Aim 1, we will characterize the role of NRF2-ACSS2 axis in mediating alcohol-induced metabolic reprogramming in human esophageal squamous epithelial cells in vitro. In Aim 2, we will validate the role of the NRF2-ACSS2 axis in mediating alcohol-induced metabolic reprogramming in mouse esophagus in vivo. In Aim 3, we will examine the inhibitory effects of NRF2 and ACSS2 inhibitors on alcohol-induced metabolic reprogramming and esophageal pathology in vivo. If the hypothesis proved to be true, these studies will lay down a solid mechanistic foundation for NRF2/ACSS2 inhibition as a novel mechanism-based preventive measure against alcohol-associated esophageal pathology in the future.
Research team
- Xiaoxin Luke ChenPI
- Guofang ZhangPI
LOADING MOONBASE SCORE
Questions for Coriell Institute for Medical Research
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Coriell Institute for Medical ResearchNot yet scored
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
Xiaoxin Luke Chen · $618K · 2020–2025
- NIH · Coriell Institute for Medical ResearchNot yet scored
Coriell Cell Engineering Center to Support National Biobanking Infrastructure
Nahid Turan · $5.0M · 2025–2030
- NIH · Coriell Institute for Medical ResearchNot yet scored
Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists
Jian Huang · $128K · 2024–2026